Feature | November 15, 2013| Dave Fornell, DAIC editor

Micro Pacemaker May Help Revolutionize Electrophysiology

nanostim pacemaker, SJM

It was just a couple years ago in a session at the American College of Cardiology on possible science-fiction-type cardiac technologies of the future that I first saw a slide of experimental, tiny catheter-delivered pacemakers that may some day revolutionize the field of electrophysiology (EP). In October, one of those science fiction devices, the Nanostim pacemaker, was granted market clearance in Europe and it was announced the vendor is in discussions to enter U.S clinical trials. I’m sure it is the first of many new miniaturized EP devices to come that will significantly change how patients with arrhythmias are treated.

When attending cardiology conferences, I am always on the lookout for “sexy” new technologies.  This admittedly is sometimes difficult to find among a sea of academic sessions and vendors on the expo floor who are always attempting to peddle what they perceive to be the greatest invention since sliced bread. However, the Nanostim is definitely one of those rare sexy technologies that we usually only find in the fictional worlds of futuristic Hollywood movies.

The tiny device, about the size of the head of a pen, can be delivered via a delivery catheter through the venous system and placed directly into the myocardium of the right ventricle.  The system eliminates the need for surgery to create a pocket under the skin for the device, or to install traditional leads.  This greatly simplifies the procedure and reduces the risk of potential complications such as infection, or the need to remove old leads years in the future. The simplified procedure cuts implant time down to an average of 28 minutes. 

One of the biggest issues facing EP is device battery life, as patients live longer or have devices implanted at a younger age. Even with miniaturization, Nanostim’s battery is expected to have an average lifespan of more than nine years at 100 percent pacing, or more than 13 years at 50 percent. 

Speaking of battery replacement, another advantage of the system is that it was designed to be fully retrievable so it can be readily repositioned during the implant procedure, or later retrieved for normal battery replacement.

What I find more intriguing are the possibilities this type of device may have on simplifying the practice of EP, possibly offering a way to more efficiently treat larger numbers of patients at a lower cost.  The delivery of this type of device might also open the possibility of implants by new operators, such as interventional cardiologists.  This might have the biggest impact in rural areas of the United States or in developing countries, where EP specialists are often rare.  

For more on the Nanostim and other EP technology developments in 2013 click here, or watch a video showing the Nanostim implantation procedure.

Related Content

Inventory management, Cardinal, RFID inventory tracking, cath lab inventory
Sponsored Content | Whitepapers | Inventory Management| October 18, 2016
As healthcare moves into the era of bundled payments, providers need to be especially focused on ensuring delivery of
Medtronic, FIRE AND ICE trial, Arctic Front, cryoballoon catheter ablation, radiofrequency RF ablation, study results, Asia Pacific Heart Rhythm Society Scientific Sessions
News | Ablation Systems| October 17, 2016
Medtronic plc last week unveiled new health economic analysis data from the FIRE AND ICE trial that favor cryoballoon...
Medtronic, FDA approval, MRI, MR-conditional scanning, cardiac devices
Technology | EP Lab| October 13, 2016
Medtronic plc is the first company to receive U.S. Food and Drug Administration (FDA) approval for its suite of cardiac...
News | Renal Denervation| October 11, 2016
Awards from the National Institutes of Health’s Common Fund are supporting research on the peripheral nervous system,...
ZipLine Medical, Zip Surgical Skin Closure, cath lab time savings, PACE study
News | EP Lab| October 10, 2016
October 10, 2016 — ZipLine Medical Inc.
St. Jude Medical, Ensite Precision cardiac mapping system, full European market release
News | EP Mapping and Imaging Systems| October 06, 2016
St. Jude Medical Inc. announced a full market release of its EnSite Precision cardiac mapping system and new Sensor...
CardioKinetix, Parachute device, Heart Failure device therapy

The CardioKinetix Parachute device implant shown deployed in the left ventricle of a heart failure patient. The device helps remodel the ventricle to improve the heart's ability to pump blood more efficiently. 

Feature | Heart Failure| September 29, 2016 | Abha Mishra
New cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF) are rapidly evolving with the
Infinix 4D CT

Toshiba's Infinix 4D CT, which combines CT with angiography in the interventional lab.

Feature | Angiography| September 28, 2016 | Tom Watson BS, RCVT, Clinical Analyst, MD Buyline
One of the more significant advancements for interventional X-ray (IXR) in the past few years has been a significantl
European Heart Rhythm Association, EHRA White Book 2016, EP Europace supplement, cardiac rhythm device use, Europe
News | EP Lab| September 27, 2016
In August, the European Heart Rhythm Association (EHRA) and EP Europace journal announced the release of the supplement...
Sponsored Content | Videos | Inventory Management| September 21, 2016
With bundled payments putting increased pressure on hospitals to manage supply costs while providing quality patient
Overlay Init